🟢 Moleculin Biotech is trading 6.65% up in pre-market with no clear company-specific catalyst identified

Moleculin Biotech is trading 6.65% up at $0.80 after no clear company-specific catalyst was identified for September 09, 2026.

• The official release page lists its latest announcement as August 27, concerning CEO participation in a virtual investor conference.
• Broader markets were essentially flat in early trading, so the pre-market move cannot be confidently attributed to market-wide momentum.
• The latest clinical and financial updates remain prior context, not confirmed same-day catalysts.